Tag: Eczema
Greater Fine Particulate Matter Linked to Increased Odds of Eczema
In multivariable analyses after adjustment for demographics and smoking status, odds ratio was 2.21 for eczema in areas with higher PM2.5
Long-Term Upadacitinib Use Feasible for Adolescents With Atopic Dermatitis
Findings seen through 76 weeks of treatment for adolescents taking 15- or 30-mg doses for moderate-to-severe atopic dermatitis
Long-Term Efficacy for Lebrikizumab Seen in Moderate, Severe Eczema
Long-term efficacy seen for lebrikizumab every two weeks or every four weeks in moderate-to-severe atopic dermatitis
FDA Approves Ebglyss for Moderate-to-Severe Atopic Dermatitis
Approval is for new, first-line biologic treatment of eczema that is not well controlled with topicals in people 12 years and older
Link Between n-3 LCPUFA, Eczema Varies by Maternal COX1 Genotype
Risk for AD was lower in the n-3 LCPUFA versus placebo group among mothers with the TT genotype
Dietary Vitamin E May Be Protective Against Atopic Dermatitis
Vitamin C, retinol, and carotene are not causally tied to atopic dermatitis
Dupilumab Maintains Its Effectiveness Up to Five Years in Patients With Eczema
23.8 percent of patients discontinued dupilumab, with adverse events and ineffectiveness the most common reasons
Gen Z Perceives Atopic Dermatitis to Be More Severe
Perceived severity higher among Gen Z compared with millennial patients
Atopic Dermatitis Has Large Impact on Sexual Function Among Women
About half of women considered that atopic dermatitis may influence their gestational desire
FDA Approves Zoryve for Atopic Dermatitis
The once-daily, nonsteroidal cream is approved for adults and children 6 years and older
